1
views
0
recommends
+1 Recommend
1 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Effective bubble-based testing for SARS-CoV-2 using swab-pooling

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Objectives

          Despite the success in developing COVID-19 vaccines, containment of the disease is obstructed worldwide by vaccine production bottlenecks, logistics hurdles, refusal to be vaccinated, transmission through unvaccinated children, and the appearance of new viral variants. This underscores the need for effective strategies for identifying carriers/patients which was the main aim of this study.

          Methods

          We present a bubble-based PCR testing approach using swab-pooling into lysis buffer. A bubble is a cluster of people who can be periodically tested for SARS-CoV-2 by swab-pooling. A positive test of a pool mandates quarantining each of its members, who are then individually tested while in isolation, to identify the carrier(s) for further epidemiological contact tracing.

          Results

          We tested an overall sample of 25,831 individuals, divided into 1273 bubbles, with an average size of 20.3±7.7 swabs/test-tube, getting for all pools (≤37 swabs/pool) a specificity of 97.5% (lower bound 96.6%) and a sensitivity of 86.3% (lower bound 78.2%), and a post-hoc analyzed sensitivity of 94.6% (lower bound 86.7%) and a specificity of 97.2% (lower bound 96.2%) in pools with ≤25 swabs, relative to individual testing.

          Conclusions

          This approach offers significant scale-up in sampling and testing throughput, savings in testing cost, while not reducing sensitivity and not affecting the standard PCR testing laboratory routine. It can be used in school classes, airplanes, hospitals, military units and workplaces, and may be applicable to future pandemics.

          Graphical abstract

          Related collections

          Most cited references28

          • Record: found
          • Abstract: found
          • Article: not found

          Temporal dynamics in viral shedding and transmissibility of COVID-19

          We report temporal patterns of viral shedding in 94 patients with laboratory-confirmed COVID-19 and modeled COVID-19 infectiousness profiles from a separate sample of 77 infector-infectee transmission pairs. We observed the highest viral load in throat swabs at the time of symptom onset, and inferred that infectiousness peaked on or before symptom onset. We estimated that 44% (95% confidence interval, 25-69%) of secondary cases were infected during the index cases' presymptomatic stage, in settings with substantial household clustering, active case finding and quarantine outside the home. Disease control measures should be adjusted to account for probable substantial presymptomatic transmission.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic period

            It is urgent to understand the future of severe acute respiratory syndrome–coronavirus 2 (SARS-CoV-2) transmission. We used estimates of seasonality, immunity, and cross-immunity for betacoronaviruses OC43 and HKU1 from time series data from the USA to inform a model of SARS-CoV-2 transmission. We projected that recurrent wintertime outbreaks of SARS-CoV-2 will probably occur after the initial, most severe pandemic wave. Absent other interventions, a key metric for the success of social distancing is whether critical care capacities are exceeded. To avoid this, prolonged or intermittent social distancing may be necessary into 2022. Additional interventions, including expanded critical care capacity and an effective therapeutic, would improve the success of intermittent distancing and hasten the acquisition of herd immunity. Longitudinal serological studies are urgently needed to determine the extent and duration of immunity to SARS-CoV-2. Even in the event of apparent elimination, SARS-CoV-2 surveillance should be maintained since a resurgence in contagion could be possible as late as 2024.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Prevalence of Asymptomatic SARS-CoV-2 Infection

              Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has spread rapidly throughout the world since the first cases of coronavirus disease 2019 (COVID-19) were observed in December 2019 in Wuhan, China. It has been suspected that infected persons who remain asymptomatic play a significant role in the ongoing pandemic, but their relative number and effect have been uncertain. The authors sought to review and synthesize the available evidence on asymptomatic SARS-CoV-2 infection. Asymptomatic persons seem to account for approximately 40% to 45% of SARS-CoV-2 infections, and they can transmit the virus to others for an extended period, perhaps longer than 14 days. Asymptomatic infection may be associated with subclinical lung abnormalities, as detected by computed tomography. Because of the high risk for silent spread by asymptomatic persons, it is imperative that testing programs include those without symptoms. To supplement conventional diagnostic testing, which is constrained by capacity, cost, and its one-off nature, innovative tactics for public health surveillance, such as crowdsourcing digital wearable data and monitoring sewage sludge, might be helpful.
                Bookmark

                Author and article information

                Journal
                Clin Microbiol Infect
                Clin Microbiol Infect
                Clinical Microbiology and Infection
                The Author(s). Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.
                1198-743X
                1469-0691
                17 February 2022
                17 February 2022
                Affiliations
                [1 ]Directorate of Defense Research & Development, Israeli Ministry of Defense, Tel Aviv 6473424, Israel
                [2 ]Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer 5265601, Israel
                [3 ]Dept. of Epidemiology and Preventive Medicine, School of Public Health, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv 69978, Israel
                [4 ]Independent researcher, 7 Yaakov Schreiboim St., Jerusalem 9371237, Israel
                [5 ]MyHeritage Lab, Petach Tikva 4951025, Israel
                [6 ]Department of Statistics and Operations Research, Tel Aviv University, Tel Aviv 69978. Israel
                [7 ]Department of Biotechnology, Hadassah Academic College, Jerusalem 9101001, Israel
                [8 ]Dept. of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel
                Author notes
                []Corresponding author. , Dept. of Biomolecular Sciences, Weizmann Institute of Science, Rehovot 7610001, Israel; Tel.: +972 8 9343203.
                [∗∗ ]Corresponding author. , Central Virology Laboratory, Ministry of Health, Chaim Sheba Medical Center, Tel-Hashomer 5265601, Israel; Tel.: +972 3 5302458.
                [1]

                These authors equally contributed to the study.

                Article
                S1198-743X(22)00090-8
                10.1016/j.cmi.2022.02.016
                8849906
                35182758
                ae86fb44-4be3-4c6b-aa2e-a97dac5f173a
                © 2022 The Author(s)

                Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.

                History
                : 16 August 2021
                : 3 February 2022
                : 8 February 2022
                Categories
                Original Article

                Microbiology & Virology
                Microbiology & Virology

                Comments

                Comment on this article